1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. United States >
  5. Vermont >
  6. Edgewater Capital Partners Acquires Prolytix

M&A Deal Summary

Edgewater Capital Partners Acquires Prolytix

On October 11, 2019, private equity firm Edgewater Capital Partners acquired life science company Prolytix

Acquisition Highlights
  • This is Edgewater Capital Partners’ 2nd transaction in the Life Science sector.
  • This is Edgewater Capital Partners’ 21st transaction in the United States.
  • This is Edgewater Capital Partners’ 1st transaction in Vermont.

M&A Deal Summary
Date 2019-10-11
Target Prolytix
Sector Life Science
Buyer(s) Edgewater Capital Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

Prolytix

Essex Junction, Vermont, United States
Prolytix is a provider of research reagents, customized blood collection tubes, and protein biochemistry services including assay development, validation, and GMP release and stability testing. Prolytix provides contract research and development services such as custom protein purification, protein modification, assay development, GMP stability, and release testing, and offers over 150 high-quality blood coagulation products including proteins, antibodies, inhibitors and substrates, deficient plasmas, custom IVD/POC reagents, and custom blood/specimen collection tubes. Prolytix was founded in 1987 and is based in Essex Junction, Vermont.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Edgewater Capital Partners

Cleveland, Ohio, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1982
Size Middle-Market
Type Sector Focused
DESCRIPTION

Edgewater Capital Partners is a private equity firm focused on acquiring established, lower middle-market companies. Prospective investment situations include corporate divestitures, management buyouts, and family business liquidity. The Firm's industry preferences include highly-engineered manufacturing, specialty chemicals, specialty Industrials, Life Science. Edgewater Capital Partners was formed in 1982 and is based in Cleveland, Ohio.

DEAL STATS #
Overall 21 of 31
Sector: Life Science M&A 2 of 4
Type: Buyout (LBO, MBO, MBI) M&A Deals 13 of 15
State: Vermont M&A 1 of 1
Country: United States M&A 21 of 30
Year: 2019 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-29 FAR Chemical

Palm Bay, Florida, United States

FAR Chemical, Inc. is a manufacture of specialty organic chemicals for customers in industries including pharmaceuticals, structural composites, CASE and foam, electronics, flavors, fragrances and personal care, catalysts, polymers and plastics. FAR Chemical, Inc. was founded in 1982 and is based in Palm Bay, Florida.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-14 Particle Dynamics

Saint Louis, Missouri, United States

Particle Dynamics engages in particle processing technologies and finished dose manufacturing, providing a wide range of products and services to the nutraceutical, consumer health, OTC, and pharmaceutical sectors. Particle Dynamics is also a recognized global leader in the supply of highly functional materials and a variety of microencapsulated vitamins, minerals, and OTC active pharmaceutical ingredients. Particle Dynamics was founded in 1990 and is based in Saint Louis, Missouri.

Sell -
Mergr

Solution for

Product

Company

Legal